M. Monconduit

8.1k total citations · 2 hit papers
45 papers, 4.1k citations indexed

About

M. Monconduit is a scholar working on Pathology and Forensic Medicine, Hematology and Genetics. According to data from OpenAlex, M. Monconduit has authored 45 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 21 papers in Hematology and 16 papers in Genetics. Recurrent topics in M. Monconduit's work include Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Multiple Myeloma Research and Treatments (7 papers). M. Monconduit is often cited by papers focused on Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Multiple Myeloma Research and Treatments (7 papers). M. Monconduit collaborates with scholars based in France, Netherlands and Belgium. M. Monconduit's co-authors include H Piguet, Thierry Façon, Laurent Voillat, Michel Attal, Denis Caillot, Hervé Tilly, Claude Lesty, G Vaugier, M. Thomas and J. Goasguen and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

M. Monconduit

44 papers receiving 3.9k citations

Hit Papers

A new prognostic classification of chronic lymphocytic le... 1981 2026 1996 2011 1981 2003 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis
    1981 1.3k citations J L Binet, Ariane Auquier et al. Cancer profile →
  2. Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma
    2003 699 citations Michel Attal, Jean Roy et al. New England Journal of Medicine profile →

Peers

M. Monconduit
Marı́a Rozman Spain
E Montserrat Spain
J M Bennett United States
Mathias Rummel Germany
Jeffrey Matous United States
Ercole Brusamolino Italy
Preetesh Jain United States
Angelo Michele Carella Italy
F Reyes France
Aspasia Stamatoullas France
Marı́a Rozman Spain
M. Monconduit
Citations per year, relative to M. Monconduit M. Monconduit (= 1×) peers Marı́a Rozman

Countries citing papers authored by M. Monconduit

Since Specialization
Citations

This map shows the geographic impact of M. Monconduit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Monconduit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Monconduit more than expected).

Fields of papers citing papers by M. Monconduit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Monconduit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Monconduit. The network helps show where M. Monconduit may publish in the future.

Co-authorship network of co-authors of M. Monconduit

This figure shows the co-authorship network connecting the top 25 collaborators of M. Monconduit. A scholar is included among the top collaborators of M. Monconduit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Monconduit. M. Monconduit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Monconduit, M.. (2016). Le système de santé français, espoirs et réalités. Études. Juillet-Août(7). 43–56. 1 indexed citations
2.
Noordijk, Evert M., Patrice Carde, N. Dupouy, et al.. (2006). Combined-Modality Therapy for Clinical Stage I or II Hodgkin's Lymphoma: Long-Term Results of the European Organisation for Research and Treatment of Cancer H7 Randomized Controlled Trials. Journal of Clinical Oncology. 24(19). 3128–3135. 149 indexed citations
3.
Attal, Michel, Jean‐Luc Harousseau, Serge Leyvraz, et al.. (2006). Maintenance therapy with thalidomide improves survival in patients with multiple myeloma. Blood. 108(10). 3289–3294. 447 indexed citations
4.
Moreau, Philippe, Frédéric Garban, Ibrahim Yakoub‐Agha, et al.. (2005). Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol. Blood. 107(1). 397–403. 61 indexed citations
5.
Attal, Michel, Jean Roy, Thierry Façon, et al.. (2003). Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma. New England Journal of Medicine. 349(26). 2495–2502. 699 indexed citations breakdown →
6.
Stamatoullas, Aspasia, Christophe Fruchart, Dominique Boulet, et al.. (1996). Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma. Cancer. 77(11). 2302–2307. 21 indexed citations
7.
Borg, Jeanne‐Yvonne, et al.. (1995). Co‐segregation of thrombosis with the factor V Q506 mutation in an extended family with resistance to activated protein C. British Journal of Haematology. 89(3). 659–662. 5 indexed citations
8.
9.
Vasse, Marc, et al.. (1994). Resistance to activated protein c: Evaluation of three functional assays. Thrombosis Research. 76(1). 47–59. 35 indexed citations
10.
11.
Lenormand, Bernard, Jean Pierre Vannier, Marie C. Béné, et al.. (1993). CD2+ CD19+ acute lymphoblastic leukaemia in 16 children and adults: clinical and biological features. The Groupe d'Etude Immunologique des Leucémies (G.E.I.L.). British Journal of Haematology. 83(4). 580–588. 5 indexed citations
12.
Lenormand, Bernard, et al.. (1992). Immunological evaluation of harvested stem cells obtained by leukapheresis after chemotherapy. American Journal of Hematology. 39(3). 172–175. 12 indexed citations
13.
Henry‐Amar, M., Samuel Friedman, Marcel Hayat, et al.. (1991). Erythrocyte Sedimentation Rate Predicts Early Relapse and Survival in Early-Stage Hodgkin Disease. Annals of Internal Medicine. 114(5). 361–365. 67 indexed citations
14.
Burgers, J. M. V., R. Somers, M. Henry‐Amar, et al.. (1991). Management of relapse and survival in advanced stage Hodgkin’s disease: The EORTC experience. Annals of Oncology. 2 Suppl 2. 63–66. 11 indexed citations
15.
Meerwaldt, J.H., Patrice Carde, J. M. V. Burgers, et al.. (1991). Low-dose total body irradiation versus combination chemotherapy for lymphomas with follicular growth pattern. International Journal of Radiation Oncology*Biology*Physics. 21(5). 1167–1172. 28 indexed citations
16.
Henry‐Amar, M., M. Hayat, J.H. Meerwaldt, et al.. (1990). Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. International Journal of Radiation Oncology*Biology*Physics. 19(5). 1155–1157. 80 indexed citations
17.
Vasse, Marc, J.Y. Borg, & M. Monconduit. (1989). Protein C : Rouen, a new hereditary protein C abnormality with low anticoagulant but normal amidolytic activities. Thrombosis Research. 56(3). 387–398. 12 indexed citations
18.
Carde, Patrice, J M Burgers, M. Henry‐Amar, et al.. (1988). Clinical stages I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors.. Journal of Clinical Oncology. 6(2). 239–252. 118 indexed citations
19.
Monconduit, M., et al.. (1987). Prognostic value of response after three MOPP cycles in hodgkin's disease ? stage III and IV. Annals of Hematology. 54(3). 171–177. 4 indexed citations
20.
Binet, J L, Ariane Auquier, Guillaume Dighiero, et al.. (1981). A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 48(1). 198–206. 1282 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marı́a Rozman Breakdown of academic impact, for papers by E Montserrat Breakdown of academic impact, for papers by J M Bennett Breakdown of academic impact, for papers by Mathias Rummel Breakdown of academic impact, for papers by Jeffrey Matous Breakdown of academic impact, for papers by Ercole Brusamolino Breakdown of academic impact, for papers by Preetesh Jain Breakdown of academic impact, for papers by Angelo Michele Carella Breakdown of academic impact, for papers by F Reyes Breakdown of academic impact, for papers by Aspasia Stamatoullas
Rankless by CCL
2026